477
Views
11
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy of cough-variant asthma

, MD, , MD PhD & , MD
Pages 3021-3028 | Published online: 15 Nov 2007

Bibliography

  • DICPINIGAITIS PV: Cough. 4. Cough in asthma and eosinophilic bronchitis. Thorax (2004) 59(1):71-72.
  • REDINGTON A: Cough variant asthma. In: Acute and Chronic Cough. Redington A, Morice AH (Eds), Taylor & Francis Group (2005):303-322.
  • GLAUSER F: Variant asthma. Ann. Allergy (1972) 30:457-459.
  • DICPINIGAITIS PV: Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest (2006) 129(1 Suppl.):S75-S79.
  • ABOUZGHEIB W, PRATTER MR, BARTTER T: Cough and asthma. Curr. Opin. Pulm. Med. (2007) 13(1):44-48.
  • KANG H, KOH YY, YOO Y et al.: Maximal airway response to methacholine in cough-variant asthma: comparison with classic asthma and its relationship to peak expiratory flow variability. Chest (2005) 128(6):3881-3887.
  • GIBSON PG, FUJIMURA M, NIIMI A: Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax (2002) 57(2):178-182.
  • FUJIMURA M, OGAWA H, NISHIZAWA Y, NISHI K: Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax (2003) 58(1):14-18.
  • CHANG AB: Cough: a children really different to adults? Cough (2005) 20:1-7.
  • MORICE AH, MCGARVEY L, PAVORD I; ON BEHALF OF THE BRITISH THORACIC SOCIETY COUGH GUIDELINE G: Recommendations for the management of cough in adults. Thorax (2006) 61(Suppl. 1):I1-I24.
  • NIIMI A, TORREGO A, NICHOLSON AG, COSIO BG, OATES TB, CHUNG KF: Nature of airway inflammation and remodeling in chronic cough. J. Allergy Clin. Immunol. (2005) 116(3):565-570.
  • NIIMI A, MATSUMOTO H, MINAKUCHI M, KITAICHI M, AMITANI R: Airway remodelling in cough-variant asthma. Lancet (2000) 356(9229):564-565.
  • FUJIMURA M, SONGUR N, KAMIO Y, MATSUDA T: Detection of eosinophils in hypertonic saline-induced sputum in patients with chronic nonproductive cough. J. Asthma (1997) 34(2):119-126.
  • OKADA C, HORIBA M, MATSUMOTO H et al.: A study of clinical features of cough variant asthma. Int. Arch. Allergy Immunol. (2001) 125(Suppl. 1):51-54.
  • DE DIEGO A, MARTINEZ E, PERPINA M et al.: Airway inflammation and cough sensitivity in cough-variant asthma. Allergy (2005) 60(11):1407-1411.
  • CHATKIN JM, ANSARIN K, SILKOFF PE et al.: Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am. J. Respir. Crit. Care Med. (1999) 159(6):1810-1813.
  • KANAZAWA H, EGUCHI Y, NOMURA N, YOSHIKAWA J: Analysis of vascular endothelial growth factor levels in induced sputum samples from patients with cough variant asthma. Ann. Allergy Asthma Immunol. (2005) 95(3):266-271.
  • LEE SY, KIM MK, SHIN C et al.: Substance P-immunoreactive nerves in endobronchial biopsies in cough-variant asthma and classic asthma. Respiration (2003) 70(1):49-53.
  • CHANG AB, PHELAN PD, ROBERTSON CF: Cough receptor sensitivity in children with acute and non-acute asthma. Thorax (1997) 52(9):770-774.
  • DICPINIGAITIS PV: Antitussive effects of leukotriene receptor antagonists. Eur. Respir. Rev. (2002) 12(85):275-277.
  • DOHERTY MJ, MISTER R, PEARSON MG, CALVERLEY PM: Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax (2000) 55(8):643-649.
  • FUJIMURA M, KAMIO Y, HASHIMOTO T, MATSUDA T: Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy. J. Asthma (1994) 31(6):463-472.
  • NIETO L, DE DIEGO A, PERPINA M et al.: Cough reflex testing with inhaled capsaicin in the study of chronic cough. Respir. Med. (2003) 97(4):393-400.
  • FUJIMURA M, NISHIZAWA Y, NISHITSUJI M et al.: Longitudinal decline in pulmonary function in atopic cough and cough variant asthma. Clin. Exp. Allergy (2003) 33(5):588-594.
  • MATSUMOTO H, NIIMI A, TABUENA RP et al.: Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough. Chest (2007) 131(4):1042-1049.
  • NIIMI A, CHUNG KF: Airway inflammation and remodelling changes in patients with chronic cough: do they tell us about the cause of cough? Pulm. Pharmacol. Ther. (2004) 17(6):441-446.
  • MELLO CJ, IRWIN RS, CURLEY FJ: Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch. Intern. Med. (1996) 156(9):997-1003.
  • KASTELIK JA, THOMPSON RH, AZIZ I et al.: Sex-related differences in cough reflex sensitivity in patients with chronic cough. Am. J. Respir. Crit. Care Med. (2002) 166(7):961-964.
  • YAHAV Y, KATZNELSON D, BENZARAY S: Persistent cough a forme-fruste of asthma. Eur. J. Respir. Dis. (1982) 63(1):43-46.
  • HANNAWAY P, HOPPER DK: Cough variant asthma in children. J. Am. Med. Assoc. (1982) 247:206-208.
  • KOH Y, PARK Y, KIM CK: The maximal airway response to methacoline in the prediction of wheezing development in patients with cough-variant asthma. Allergy (2002) 57:1165-1170.
  • NAKAJIMA T, NISHIMURA Y, NISHIUMA T et al.: Characteristics of patients with chronic cough who developed classic asthma during the course of cough variant asthma: a longitudinal study. Respiration (2005) 72(6):606-611.
  • FUJIMURA M, NISHIZAWA Y, NISHITSUJI M et al.: Predictors for typical asthma onset from cough variant asthma. J. Asthma (2005) 42(2):107-111.
  • FUJIMURA M, HARA J, MYOU S: Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough (2005) 1:5.
  • TODOKORO M, MOCHIZUKI H, TOKUYAMA K, MORIKAWA A: Childhood cough variant asthma and its relationship to classic asthma. Ann. Allergy Asthma Immunol. (2003) 90(6):652-659.
  • MATSUMOTO HNA, TAKEMURA M, UEDA T et al.: Prognosis of cough variant asthma: a retrospective analysis. J. Asthma (2006) 43(2):131-135.
  • MORICE AH, MCGARVEY L, PAVORD I: Recommendations for the management of cough in adults. Thorax (2006) 61(Suppl. 1):I1-I24.
  • NISHITSUJI M, FUJIMURA M, ORIBE Y, NAKAO S: A guinea pig model for cough variant asthma and role of tachykinins. Exp. Lung Res. (2004) 30(8):723-737.
  • IRWIN RS, FRENCH CT, SMYRNIOS NA, CURLEY FJ: Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma. Arch. Intern. Med. (1997) 157(17):1981-1987.
  • FUJIMURA M, SAKAMOTO S, MATSUDA T: Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness. Intern. Med. (1992) 31(4):447-452.
  • TOMERAK A, VYAS H, LAKHANPAUL M, MCGLASHAN JJM, MCKEAN M: Inhaled β2-agonists for non-specific chronic cough in children. Cochrane Database Syst. Rev. (2005) (3):CD005373.
  • DOAN T, PATTERSON R, GREENBERGER PA: Cough variant asthma: usefulness of a diagnostic-therapeutic trial with prednisone. Ann. Allergy (1992) 69(6):505-509.
  • DI FRANCO A, DENTE FL, GIANNINID et al.: Effects of inhaled corticosteroids on cough threshold in patients with bronchial asthma. Pulm. Pharmacol. Ther. (2001) 14(1):35-40.
  • CHERIYAN S, GREENBERGER PA, PATTERSON R: Outcome of cough variant asthma treated with inhaled steroids. Ann. Allergy (1994) 73(6):478-480.
  • TOMERAK AAT MJ, LAKHANPAUL M, VYAS HHV, MCKEAN MC: Inhaled corticosteroids for non-specific chronic cough in children. Cochrane Database Syst. Rev. (2005) (4):CD004231.
  • DRAZEN JM: Leukotrienes as mediators of airway obstruction. Am. J. Respir. Crit. Care Med. (1998) 158(5 Part 3):S193-S200.
  • CAPRA V, ROVATI GE: Leukotriene modifiers in asthma management. IDrugs (2004) 7(7):659-666.
  • HOLGATE ST, PETERS-GOLDEN M, PANETTIERI RA, HENDERSON WR Jr: Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J. Allergy Clin. Immunol. (2003) 111(1 Suppl.):S18-S34; discussion S34-S36.
  • MACFARLANE AJ, DWORSKI R, SHELLER JR et al.: Sputum cysteinyl leukotrienes increase 24 h after allergen inhalation in atopic asthmatics. Am. J. Respir. Crit. Care Med. (2000) 161(5):1553-1558.
  • LAM S, CHAN H, LERICHE JC, CHAN-YEUNG M, SALARI H: Release of leukotrienes in patients with bronchial asthma. J. Allergy Clin. Immunol. (1988) 81(4):711-717.
  • PAVORD ID, WARD R, WOLTMANN G et al.: Induced sputum eicosanoid concentrations in asthma. Am. J. Respir. Crit. Care Med. (1999) 160(6):1905-1909.
  • SCOW DT, LUTTERMOSER GK, DICKERSON KS: Leukotriene inhibitors in the treatment of allergy and asthma. Am. Fam. Physician (2007) 75(1):65-70.
  • BIRRING SS, PARKER D, BRIGHTLING CE et al.: Induced sputum inflammatory mediator concentrations in chronic cough. Am. J. Respir. Crit. Care Med. (2004) 169(1):15-19.
  • NISHITSUJI M, FUJIMURA M, ORIBE Y, NAKAO S: Effect of montelukast in a guinea pig model of cough variant asthma. Pulm. Pharmacol. Ther. (2007).
  • NISHI K, WATANABE K, OOKA T, FUJIMURA M, MATSUDA T: Cough-variant asthma successfully treated with a peptide leukotriene receptor antagonist. Nihon Kyobu Shikkan Gakkai Zasshi (1997) 35(1):117-123.
  • DICPINIGAITIS PV, DOBKIN JB, REICHEL J: Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J. Asthma (2002) 39(4):291-297.
  • DRAZEN JM, ISRAEL E, O'BYRNE PM: Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. (1999) 340(3):197-206.
  • DICPINIGAITIS PV, DOBKIN JB: Effect of zafirlukast on cough reflex sensitivity in asthmatics. J. Asthma (1999) 36(3):265-270.
  • SPECTOR SL, TAN RA: Effectiveness of montelukast in the treatment of cough variant asthma. Ann. Allergy Asthma Immunol. (2004) 93(3):232-236.
  • LU HJ, QIU ZM, WEI WL et al.: Effects of phosphodiesterase 4 inhibitor on cough response in guinea pigs sensitized and challenged with ovalbumin. Chin. Med. J. (Engl.) (2004) 117(11):1620-1624.
  • FUJIMURA M, LIU Q: Selective inhibitors for phosphodiesterase 3 and 4 in antigen-induced increase of cough reflex sensitivity in guinea pigs. Pulm. Pharmacol. Ther. (2006).
  • ISHIURA Y, FUJIMURA M, NOBATA K et al.: Phosphodiesterase 3 inhibition and cough in elderly asthmatics. Cough (2005) 1:11.
  • HORIGUCHI T, TACHIKAWA S, HANDA M et al.: Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness. J. Asthma (2001) 38(4):331-336.
  • SHIOYA T, SATAKE M, SANO M et al.: Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma. Eur. J. Clin. Pharmacol. (2002) 58(3):171-176.

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.